CRY Share Price

Open 18.15 Change Price %
High 18.35 1 Day 0.05 0.28
Low 17.85 1 Week -0.40 -2.15
Close 18.20 1 Month 1.00 5.81
Volume 133182 1 Year 7.61 71.86
52 Week High 20.15
52 Week Low 8.94
CRY Important Levels
Resistance 2 18.66
Resistance 1 18.47
Pivot 18.13
Support 1 17.93
Support 2 17.74
NYSE USA Most Active Stocks
BAC 22.57 1.85%
BAC 22.57 1.85%
BAC 22.57 1.85%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
CHK 7.58 0.00%
More..
NYSE USA Top Gainers Stocks
IPI 2.49 36.81%
IPI 2.49 36.81%
IPI 2.49 36.81%
POM 26.93 26.79%
POM 26.93 26.79%
VRS 6.20 15.24%
VRS 6.20 15.24%
CVI 21.14 14.33%
SAB 7.20 12.50%
SAB 7.20 12.50%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

CryoLife, Inc. (NYSE: CRY)

CRY Technical Analysis 4
As on 7th Dec 2016 CRY Share Price closed @ 18.20 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 13.52 & Buy for SHORT-TERM with Stoploss of 17.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
CRY Target for December
1st Target up-side 21.69
2nd Target up-side 23.13
3rd Target up-side 24.56
1st Target down-side 17.61
2nd Target down-side 16.17
3rd Target down-side 14.74
CRY Other Details
Segment EQ
Market Capital 172325952.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.cryolife.com
CRY Address
CRY
1655 Roberts Boulevard N.W.
Kennesaw, GA 30144
United States
Phone: 770-419-3355
Fax: 770-426-0031
CRY Latest News
Company Levels in Review: CryoLife, Inc. (NYSE:CRY)   Liberty News   - 05th Dec 16
VC Score In Focus for CryoLife, Inc. (NYSE:CRY)   EBJ   - 05th Dec 16
Is Cryolife Inc (CRY) A Good Stock To Buy?   Insider Monkey (blog)   - 05th Dec 16
Despite Recent Market Upturn, This Stock Struggled This Week: CryoLife, Inc ...   CSZ News   - 03rd Dec 16
Macquarie Group Ltd. Boosts Stake in CryoLife Inc. (CRY)   Community Financial News   - 02nd Dec 16
James W. Bullock Joins CryoLife Board of Directors   PR Newswire (press release)   - 26th Oct 16
CryoLife Announces Release Date and Teleconference Call Details for 2016 Third ...   PR Newswire (press release)   - 12th Oct 16
CryoLife Appoints James McDermid as Chief Human Resources Officer   PR Newswire (press release)   - 06th Sep 16
Why Cryolife Inc's Shares Turned Hot Today   Motley Fool   - 26th Jul 16
CryoLife Announces Definitive Agreement to Acquire On-X Life Technologies ...   PR Newswire (press release)   - 23rd Dec 15
Interactive Technical Analysis Chart CryoLife, Inc. ( CRY NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on CryoLife, Inc.
CRY Business Profile
CryoLife, Inc., together with its subsidiaries, develops, manufactures, and commercializes medical devices for cardiac and vascular applications; and preserves and distributes human tissues for transplantation worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers surgical sealants and hemostats, including BioGlue Surgical Adhesive, a polymeric surgical adhesive based on bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; BioFoam Surgical Matrix for use as an adjunct in the sealing of abdominal parenchymal tissues, when cessation of bleeding by ligature or conventional methods is ineffective or impractical; and PerClot, an absorbable powdered hemostat agent for use in surgical procedures. The company also provides Revascularization technologies, including Transmyocardial Revascularization system for treating patients with stable angina that is not responsive to conventional therapy; and markets HeRO Graft, a graft-based solution for end-stage renal disease hemodialysis patients with limited access options. In addition, it distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using the proprietary SynerGraft technology; and vascular tissues, such as CryoVein and CryoArtery to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company markets its products to physicians through field representatives, cardiac specialists, and independent distributors; and preservation services to organ and tissue procurement organizations, implanting physicians, and prospective tissue recipients. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.